Health
Cancer drug bought for Rs 2,700 sold at up to Rs 27,000: India's Supreme Court asks Centre to explain
In a hearing on drug price control and generic prescribing, India's Supreme Court heard that a cancer drug retailers buy for Rs 2,700 carries a maximum retail price of up to Rs 27,000, and the judges called it 'carnage', Sangbad Pratidin reports.